Safety aspects of postoperative pain management

Reviews in Analgesia

Volumn 9, Issue 1, 2006, Pages 45-53

  Tan, Tee Yong ^a   Schug, Stephan A ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Acetaminophen (paracetamol); COX 2 inhibitors (Coxibs); Epidural analgesia; Nonsteroidal anti inflammatory drugs (NSAIDs); Patient controlled analgesia (PCA); Postoperative pain; Safety

Indexed keywords

ALCOHOL; BENZODIAZEPINE; CARBAMAZEPINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; KETOROLAC; LOCAL ANESTHETIC AGENT; MORPHINE; NALOXONE; NAPROXEN; NITROPARACETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PARACETAMOL DERIVATIVE; PARECOXIB; PHENYTOIN; PROPACETAMOL; ROFECOXIB; UNCLASSIFIED DRUG; VALDECOXIB;

ASTHMA; BIOEQUIVALENCE; CARDIOVASCULAR EFFECT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE PREDISPOSITION; DRUG ALCOHOL INTERACTION; DRUG CONTRAINDICATION; DRUG SAFETY; EPIDURAL ANESTHESIA; GASTRODUODENAL ULCER; GASTROINTESTINAL SYMPTOM; HEART ARREST; HEART INFARCTION; HUMAN; HYPOTENSION; INJECTION SITE REACTION; LIVER TOXICITY; LUNG EMBOLISM; NERVE BLOCK; PATIENT CONTROLLED ANALGESIA; PATIENT SAFETY; PEPTIC ULCER BLEEDING; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; RESPIRATION DEPRESSION; REVIEW; SINGLE DRUG DOSE; STROKE; SUSTAINED RELEASE FORMULATION; THROMBOPHLEBITIS; ULCER PERFORATION;

EID: 33845964879     PISSN: 1542961X     EISSN: 15553876     Source Type: Journal    
DOI: 10.3727/000000006783992835     Document Type: Review

References (62)

1. Ardoin, S. P.; Sundy, J. S. Update on nonsteriodal antiinflammatory drugs. Curr. Opin. Rheumatol. 18:221-226; 2006.
2. Australian and New Zealand College of Anaesthetists, Faculty of Pain Medicine. Acute pain management: Scientific evidence: Melbourne, Australian and New Zealand College of Anaesthetists; 2005.
3. Baird, M. B.; Schug, S. A. Safety aspects of postoperative pain relief. Pain Digest 6:219-225; 1996.
4. Barden, J.; Edwards, J.; Moore, A.; McQuay, H. Single dose oral paracetamol (acetaminophen) for postoperative pain. Cochrane Database of Systematic Reviews CD004602; 2004.
5. Bates, D. W.; Cullen, D. J.; Laird, N.; Petersen, L. A.; Small, S. D.; Servi, D.; Laffel, G.; Sweitzer, B. J.; Shea, B. F.; Hallisey, R.; et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274:29-34; 1995.
6. Bombardier, C.; Laine, L.; Reicin, A.; Shapiro, D.; Burgos-Vargas, R.; Davis, B.; Day, R.; Ferraz, M. B.; Hawkey, C. J.; Hochberg, M. C.; Kvien, T. K.; Schnitzer, T. J. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N. Engl. J. Med. 343:1520-1528; 2000.
7. Bresalier, R. S.; Sandler, R. S.; Quan, H.; Bolognese, J. A.; Oxenius, B.; Morgan, K.; Lines, C.; Riddell, R.; Morton, D.; Lanas, A.; Konstam, M. A.; Baron, J. A. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 352:1092-1102; 2005.
8. Cashman, J. N.; Dolin, S. J. Respiratory and haemodynamic effects of acute postoperative pain management: Evidence from published data. Br. J. Anaesth. 93:212-223; 2004.
9. Chen, P. P.; Ma, M.; Chan, S.; Oh, T. E. Incident reporting in acute pain management. Anaesthesia 53:730-735; 1998.
10. Dart, R. C.; Green, J. L.; Bogdan, G. M. The safety profile of sustained release paracetamol during therapeutic use and following overdose. Drug Saf. 28:1045-1056; 2005.
11. Dolin, S. J.; Cashman, J. N. Tolerability of acute postoperative pain management: nausea, vomiting, sedation, pruritis, and urinary retention. Evidence from published data. Br. J. Anaesth. 95:584-591; 2005.
12. Dolin, S. J.; Cashman, J. N.; Bland, J. M. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br. J. Anaesth. 89:409-423; 2002.
13. Elia, N.; Lysakowski, C.; Tramer, M. R. Does multimodal analgesia with acetaminophen, nonsteroidal anti-inflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 103:1296-1304; 2005.
14. Flouvat, B.; Leneveu, A.; Fitoussi, S.; Delhotal-Landes, B.; Gendron, A. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Int. J. Clin. Pharmacol. Ther. 42:50-57; 2004.
15. Gan, T. J.; Joshi, G. P.; Viscusi, E.; Cheung, R. Y.; Dodge, W.; Fort, J. G.; Chen, C. Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectorny surgery. Anesth. Analg. 98:1665-1673; 2004.
16. Gerstenfeld, L. C.; Thiede, M.; Seibert, K.; Mielke, C.; Phippard, D.; Svagr, B.; Cullinane, D.; Einhorn, T. A. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J. Orthop. Res. 21:670-675; 2003.
17. Glassman, S. D.; Rose, S. M.; Dimar, J. R.; Puno, R. M.; Campbell, M. J.; Johnson, J. R. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 23:834-838; 1998.
18. Gottschalk, A.; Cohen, S. P.; Yang, S.; Ochroch, E. A. Preventing and treating pain after thoracic surgery. Anesthesiology 104:594-600; 2006.
19. Graham, G. G.; Scott, K. F.; Day, R. O. Tolerability of paracetamol. Drug Saf. 28:227-240; 2005.
20. Grass, J. A. Patient-controlled analgesia. Anesth. Analg. 101:844-61; 2005.
21. Grewal, S.; Hocking, G.; Wildsmith, J. A. Epidural abscesses. Br. J. Anaesth. 96:292-302; 2006.
22. Gyllfors, P.; Bochenek, G.; Overholt, J.; Drupka, D.; Kumlin, M.; Sheller, J.; Nizankowska, E.; Isakson, P. C.; Mejza, F.; Lefkowith, J. B.; Dahlen, S. E.; Szczeklik, A.; Murray, J. J.; Dahlen, B. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J. Allergy Clin. Immunol. 111:1116-1121; 2003.
23. Harris, S. I.; Kuss, M.; Hubbard, R. C.; Goldstein, J. L. Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo. Clin. Ther. 23:1422-1428; 2001.
24. Hegi, T. R.; Bombeli, T.; Seifert, B.; Baumann, P. C.; Haller, U.; Zalunardo, M. P.; Pasch, T.; Spahn, D. R. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br. J. Anaesth. 92:523-531; 2004.
25. Jarde, O.; Boccard, E. Parenteral versus oral route increases paracetamol efficacy. Clin. Drug Invest. 14:474-481; 1997.
26. Kuffner, E. K.; Dart, R. C. Acetaminophen use in patients who drink alcohol: current study evidence. Am. J. Manag. Care 7:8592-596; 2001.
27. Lazzaroni, M.; Bianchi Porro, G. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment Pharmacol. Ther. 20(Suppl. 2):48-58; 2004.
28. Lee, A.; Cooper, M. G.; Craig, J. C.; Knight, J. F.; Keneally, J. P. The effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on postoperative renal function: a meta-analysis. Anaesth. Intensive Care 27:574-580; 1999.
29. Macintyre, P. E. Safety and efficacy of patient-controlled analgesia. Br. J. Anaesth. 87:36-46; 2001.
30. Mamdani, M.; Rochon, P. A.; Juurlink, D. N.; Kopp, A.; Anderson, G. M.; Naglie, G.; Austin, P. C.; Laupacis, A. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. Br. Med. J. 325:624; 2002.
31. Marret, E.; Flahault, A.; Samama, M.; Bonnet, F. Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology 98:1497-1502:2003.
32. Martin-Garcia, C.; Hinojosa, M.; Berges, P.; Camacho, E.; Garcia-Rodriguez, R.; Alfaya, T. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J. Invest. Allergol. Clin. Immunol. 13:20-25; 2003.
33. Martin-Garcia, C.; Hinojosa, M.; Berges, P.; Camacho, E.; Garcia-Rodriguez, R.; Alfaya, T.; Iscar, A. Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 121:1812-1817; 2002.
34. Moiniche, S.; Romsing, J.; Dahl, J. B.; Tramer, M. R. Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: A quantitative systematic review. Anesth. Analg. 96:68-77; 2003.
35. Moore, P. K.; Marshall, M. Nitric oxide releasing acetaminophen (nitroacetaminophen). Dig. Liver Dis. 35(Suppl. 2):S49-60; 2003.
36. Noveck, R. J.; Laurent, A.; Kuss, M.; Talwalker, S.; Hubbard, R. C. Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals: Two randomised, controlled trials. Clin. Drug Invest. 21:465-476; 2001.
37. Nussmeier, N. A.; Whelton, A. A.; Brown, M. T.; Joshi, G. P.; Langford, R. M.; Singla, N. K.; Boye, M. E.; Verburg, K. M. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology 104:518-526; 2006.
38. Nussmeier, N. A.; Whelton, A. A.; Brown, M. T.; Langford, R. M.; Hoeft, A.; Parlow, J. L.; Boyce, S. W.; Verburg, K. M. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N. Engl. J. Med. 352:1081-1091; 2005.
39. Ott, E.; Nussmeier, N. A.; Duke, P. C.; Feneck, R. O.; Alston, R. P.; Snabes, M. C.; Hubbard, R. C.; Hsu, P. H.; Saidman, L. J.; Mangano, D. T. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 125:1481-1492; 2003.
40. Power, I. Recent advances in postoperative pain therapy. Br. J. Anaesth. 95:43-51; 2005.
41. Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 100:1573-1581; 2004.
42. Prescott, L. F. Paracetamol: Past, present, and future. Am. J. Ther. 7:143-147; 2000.
43. Remy, C.; Marret, E.; Bonnet, F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: Meta-analysis of randomized controlled trials. Br. J. Anaesth. 94:505-513; 2005.
44. Reuben, S. S. The effects of non-steroidal anti-inflammatory drugs on spinal fusion. Acute Pain 6:41-45; 2004.
45. Reuben, S. S.; Ablett, D.; Kaye, R. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can. J. Anaesth. 52:506-512; 2005.
46. Reuben, S. S.; Ekman, E. F. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J. Bone Joint Surg. Am. 87:536-542; 2005.
47. Romsing, J.; Moiniche, S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol. Scand. 48:525-546; 2004.
48. Rowlingson, J. C. Postoperative pain: To diversify is to satisfy. Anesth. Analg. 101:81-4; 2005.
49. Schug, S. A.; Garrett, W. R.; Gillespie, G. Opioid and non-opioid analgesics. Best Pract. Res. Clin. Anaesthesiol. 17:91-110; 2003.
50. Schug, S. A.; Torrie, J. J. Safety assessment of postoperative pain management by an acute pain service. Pain 55:387-391; 1993.
51. Schug, S. A.; Zech, D.; Grond, S. Adverse effects of systemic opioid analgesics. Drug Saf. 7:200-213; 1992.
52. Sidebotham, D.; Dijkhuizen, M. R.; Schug, S. A. The safety and utilization of patient-controlled analgesia. J. Pain Symptom Manage. 14:202-209; 1997.
53. Stevenson, D. D.; Simon, R. A. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J. Allergy Clin. Immunol. 108:47-51; 2001.
54. Stoltz, R. R.; Harris, S. I.; Kuss, M. E.; LeComte, D.; Talwalker, S.; Dhadda, S.; Hubbard, R. C. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects. Am. J. Gastroenterol. 97:65-71; 2002.
55. Tam, N. L.; Pac-Soo, C.; Pretorias, P. M. Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br. J. Anaesth. 96:262-265; 2006.
56. Viscusi, E. R. Emerging techniques in the management of acute pain: Epidural analgesia. Anesth. Analg. 101:S23-29; 2005.
57. Werner, M. U.; Soholm, L.; Rotboll-Nielsen, P.; Kehlet, H. Does an acute pain service improve postoperative outcome? Anesth. Analg. 95:1361-1372; 2002.
58. Wheatley, R. G.; Schug, S. A.; Watson, D. Safety and efficacy of postoperative epidural analgesia. Br. J. Anaesth. 87:47-61; 2001.
59. Whelton, A. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and nonNSAID analgesics. Am. J. Ther. 7:63-74; 2000.
60. White, P. F. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth. Analg. 101:85-22; 2005.
61. Wu, C. L.; Cohen, S. R.; Richman, J. M.; Rowlingson, A. J.; Courpas, G. E.; Cheung, K.; Lin, E. E.; Liu, S. S. Efficacy of postoperative patient-controlled and continuous infusion epidural analgesia versus intravenous patient-controlled analgesia with opioids: A meta-analysis. Anesthesiology 103:1079-1088; 2005.
62. Zhao, S. Z.; Chung, F.; Hanna, D. B.; Raymundo, A. L.; Cheung, R. Y.; Chen, C. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J. Pain Symptom Manage. 28:35-46; 2004.